Company / Operating Margin
TENAX THERAPEUTICS, INC. Operating Margin History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-10452.1%
FY2016
5-year range
-10452.1% / -435.7%
FY2012-FY2016
Trend
+0.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -435.7% to -10452.1% over the past 2 years.
Based on SEC 10-K filings.
-10452.1% in FY2016 with a 3-year CAGR of -8192.5%.
Declined from -435.7% to -10452.1% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -8192.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, operating margin increased 0.0% year-over-year.
- Peak operating margin was recorded in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2016 | -10452.1% | +0.0% |
| FY2015 | -10452.1% | -2298.9% |
| FY2014 | -435.7% | +80.7% |
| FY2013 | -2259.7% | -122.1% |
| FY2012 | 10238.4% | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026